Transaction · 0000912282-26-001332

Glavine Paul

Glavine Paul, CGO, reported a transaction classified as grant at Helus Pharma Inc. involving 248000.000000 shares. Reported holdings after the transaction were 4750191.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code ACGO
HELPHelus Pharma Inc.
Filing timeOct 02
Trade dateSep 30, 2026
Filing · SECView on SEC
InsiderProfile
% of reported position tradedUnavailableCalculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
—
Pre-filing
1mo ago1w ago1d ago
Returns since
7d30d90d180d1y

HELP price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
HELP since 2026-10-02Filed today · pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
grant
Code A
Identifier
0000912282-26-001332
Common Shares
Transaction date
Sep 30, 2026
Filed Oct 02, 2026, 12:12 AM · 2d delay
Shares
248k sh
Price unknown
Estimated value
—
Computed from shares × price
Holdings after
4.75M sh
Direct

Filing warnings

Notes recorded with this filing
1 warning
missing priceThe filing did not provide a usable price per share.

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Direct Ownership
-20score
Filing-only score

-20

Compact filing score computed from stored Form 4 facts. Version v1.

Low filing signal

This filing has a meaningfully negative filing-only score. It is likely less useful as a positive insider-activity signal.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Growth Officer

Officer YesDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    Represents grant of 248,000 restricted stock units ("RSUs") on September 30, 2026, with immediate vesting.

  2. F2

    Each ("RSU") represents a right to receive one share of the Issuer's common stock.

  3. F3

    Includes 230,941 shares previously reported as indirect holdings by the PLG Family Trust, which have been transferred to the Reporting Person. Due to rounding, the number of shares has been reduced t…

Original filing · 0000912282-26-001332
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

HELP